Matches in SemOpenAlex for { <https://semopenalex.org/work/W137086008> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W137086008 endingPage "969" @default.
- W137086008 startingPage "965" @default.
- W137086008 abstract "Treatment of patients with psoriasis and/or psoriatic arthritis and concomitant hepatitis C infection remains difficult. Except for cyclosporine, other drugs have proved unacceptable because of hepatotoxicity in patients with HCV. With the advent of anti-TNF-alpha drugs, including etanercept, new therapeutic options have become available. Our study population was five patients with psoriasis and/or psoriatic arthritis and concomitant chronic HCV infection undergoing etanercept therapy. Serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), and viral load were used as markers for liver damage and disease progression, respectively. The Psoriasis Area Severity Index (PASI) was used as a reference parameter for evaluating the therapeutic efficacy of etanercept therapy in improving the clinical skin picture. AST, ALT, viral load and PASI were monitored at 3-month intervals starting from the beginning of therapy up to two years after initiation of etanercept therapy. In four out of five patients, liver enzyme levels and viral load remained substantially unchanged during the course of therapy. In the one remaining patient, viral load and liver enzyme levels increased during etanercept therapy, and then decreased following the initiation of Peg-IFN/ribavirin in combination with anti-TNF-alpha therapy. PASI scores decreased in all five patients. Our data suggest that etanercept therapy is safe and provides an efficacious therapeutic alternative in patients with psoriasis and concomitant HCV infection." @default.
- W137086008 created "2016-06-24" @default.
- W137086008 creator A5024572384 @default.
- W137086008 creator A5034192768 @default.
- W137086008 date "2010-07-01" @default.
- W137086008 modified "2023-09-27" @default.
- W137086008 title "Etanercept Therapy in Patients with Psoriasis and Concomitant HCV Infection" @default.
- W137086008 cites W1519438828 @default.
- W137086008 cites W179047846 @default.
- W137086008 cites W1973939528 @default.
- W137086008 cites W2027616201 @default.
- W137086008 cites W2042646216 @default.
- W137086008 cites W2075300112 @default.
- W137086008 cites W2096426963 @default.
- W137086008 cites W2102066997 @default.
- W137086008 cites W2117069079 @default.
- W137086008 cites W2117964400 @default.
- W137086008 cites W2135258589 @default.
- W137086008 cites W2142129025 @default.
- W137086008 cites W2153971935 @default.
- W137086008 cites W2170889678 @default.
- W137086008 doi "https://doi.org/10.1177/039463201002300335" @default.
- W137086008 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20943071" @default.
- W137086008 hasPublicationYear "2010" @default.
- W137086008 type Work @default.
- W137086008 sameAs 137086008 @default.
- W137086008 citedByCount "16" @default.
- W137086008 countsByYear W1370860082012 @default.
- W137086008 countsByYear W1370860082013 @default.
- W137086008 countsByYear W1370860082014 @default.
- W137086008 countsByYear W1370860082015 @default.
- W137086008 countsByYear W1370860082016 @default.
- W137086008 countsByYear W1370860082017 @default.
- W137086008 crossrefType "journal-article" @default.
- W137086008 hasAuthorship W137086008A5024572384 @default.
- W137086008 hasAuthorship W137086008A5034192768 @default.
- W137086008 hasBestOaLocation W1370860081 @default.
- W137086008 hasConcept C126322002 @default.
- W137086008 hasConcept C203014093 @default.
- W137086008 hasConcept C2776260265 @default.
- W137086008 hasConcept C2776999253 @default.
- W137086008 hasConcept C2777011040 @default.
- W137086008 hasConcept C2777226972 @default.
- W137086008 hasConcept C2777575956 @default.
- W137086008 hasConcept C2778606649 @default.
- W137086008 hasConcept C2779384505 @default.
- W137086008 hasConcept C2780564577 @default.
- W137086008 hasConcept C71924100 @default.
- W137086008 hasConcept C90924648 @default.
- W137086008 hasConceptScore W137086008C126322002 @default.
- W137086008 hasConceptScore W137086008C203014093 @default.
- W137086008 hasConceptScore W137086008C2776260265 @default.
- W137086008 hasConceptScore W137086008C2776999253 @default.
- W137086008 hasConceptScore W137086008C2777011040 @default.
- W137086008 hasConceptScore W137086008C2777226972 @default.
- W137086008 hasConceptScore W137086008C2777575956 @default.
- W137086008 hasConceptScore W137086008C2778606649 @default.
- W137086008 hasConceptScore W137086008C2779384505 @default.
- W137086008 hasConceptScore W137086008C2780564577 @default.
- W137086008 hasConceptScore W137086008C71924100 @default.
- W137086008 hasConceptScore W137086008C90924648 @default.
- W137086008 hasIssue "3" @default.
- W137086008 hasLocation W1370860081 @default.
- W137086008 hasLocation W1370860082 @default.
- W137086008 hasOpenAccess W137086008 @default.
- W137086008 hasPrimaryLocation W1370860081 @default.
- W137086008 hasRelatedWork W1973307523 @default.
- W137086008 hasRelatedWork W1994132766 @default.
- W137086008 hasRelatedWork W2009416381 @default.
- W137086008 hasRelatedWork W2058650537 @default.
- W137086008 hasRelatedWork W2082010193 @default.
- W137086008 hasRelatedWork W2082803782 @default.
- W137086008 hasRelatedWork W2161750495 @default.
- W137086008 hasRelatedWork W2168698481 @default.
- W137086008 hasRelatedWork W2287117830 @default.
- W137086008 hasRelatedWork W2811213036 @default.
- W137086008 hasVolume "23" @default.
- W137086008 isParatext "false" @default.
- W137086008 isRetracted "false" @default.
- W137086008 magId "137086008" @default.
- W137086008 workType "article" @default.